• Patient Action Center
  • Seniors Rising Now
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate

Featured

PRN and 27 Patient Groups Send Letter to Hill on Generic Drugs

PRN and 27 Patient Groups Send Letter to Hill on Generic Drugs

Nov 20, 2022 | Featured, Letters Submitted

Patients Rising Now, along with 27 other patient groups, sent a letter to Congressional leadership as well as Senate HELP committee and House E&C leadership urging support for generic drug policy riders. The 117th Congress will soon enter the final session period...
Read more
PRN and 27 Patient Groups Send Letter to Hill on Generic Drugs

Patients Rising Now Signs onto Letter of Support for Home Infusion

Oct 31, 2022 | Featured, Medicare, Uncategorized

Patients Rising Now signed onto a letter of support for the bipartisan and bicameral Preserving Patient Access to Home Infusion Act (S.2652/H.R.5067). For decades, home infusion therapy services have been a lifeline for millions of Americans by delivering lifesaving...
Read more
A Mutistakeholder Approach to Rare Disease Drug Development 

A Mutistakeholder Approach to Rare Disease Drug Development 

Oct 31, 2022 | Access, Featured

Surabhi Dangi-Garimella, Ph.D. A rare disease, by the U.S. definition, is one that afflicts less than 200,000 individuals in the population at a given time. Compared to more widespread conditions such as heart disease and diabetes, ‘rare’ diseases do not receive as...
Read more
Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Menopause Vasomotor Symptoms

Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Menopause Vasomotor Symptoms

Oct 25, 2022 | Featured, ICER, Uncategorized

On October 11, 2022, ICER released its draft evidence report, “Fezolinetant for Moderate to Severe Vasomotor Symptoms Associated with Menopause.” This document provides a framework for considering what aspects of ICER’s review are important to women and their...
Read more
PRN and 27 Patient Groups Send Letter to Hill on Generic Drugs

Patients Rising Now Signs onto Nondiscrimination in Healthcare Letter

Oct 4, 2022 | Access, Featured

Patients Rising Now signs on with 70 other patient groups to send another letter to the Department of Health and Human Services (HHS) praising the Department fortheir Proposed Rule regarding nondiscrimination in healthcare. We sent our own letter outside of this one...
Read more
PRN and 27 Patient Groups Send Letter to Hill on Generic Drugs

Patients Rising Now Sends Letter to HHS on Discrimination in Healthcare

Oct 3, 2022 | Comment Letters, Featured, Uncategorized

The Department of Health and Human Services (HHS) held a comment period on a Proposed Rule they plan to implement. The Rule reverses a previous 2020 rule that narrowed the scope of protections against discrimination in healthcare. Patients Rising Now (PRN) submitted...
Read more
« Older Entries
Next Entries »

Categories

  • Access
  • Advocacy
  • California
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Patients Rising Now Signs onto Letter to CMS on Low Income Subsidies
  • Patients Rising Now Weighs in on House E&C QALY Hearing
  • Patients Rising Now Signs on to Letter to HHS on NBPP
  • Patients Rising Now Sends Comments to CMS on EHBs
  • Rural Hospital Closures Further Complicates Healthcare Access in Mississippi

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now